denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Bristol Myers Squibb and Seagen
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Friday, December 8, 2023: 7:00 PM-10:00 PM
Marriott Grand Ballroom 11-13
(Marriott Marquis San Diego Marina)
Chair:
Alex F. Herrera, MD, City of Hope
Disclosures:
Herrera: BMS: Consultancy, Other: Travel/Accommodations/Expenses, Research Funding; Genentech/Roche: Consultancy, Research Funding; Merck: Consultancy, Research Funding; Kite, a Gilead Company: Research Funding; AstraZeneca/MedImmune: Consultancy; Karyopharm Therapeutics: Consultancy; ADC Therapeutics: Consultancy, Research Funding; Takeda: Consultancy; Tubulis GmbH: Consultancy; Regeneron: Consultancy; Genmab: Consultancy; Pfizer: Consultancy; Caribou Biosciences: Consultancy; Adicet Bio: Consultancy; AbbVie: Consultancy; Allogene Therapeutics: Consultancy; Seattle Genetics: Consultancy, Research Funding; Gilead Sciences: Research Funding; AstraZeneca: Research Funding.
Speakers:
Philippe Armand, MD, PhD, Dana-Farber Cancer Institute
and
Carla Casulo, MD, University of Rochester
Disclosures:
Armand: Merck: Consultancy, Honoraria, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; ADC Therapeutics: Consultancy; GenMab: Consultancy; Enterome: Consultancy; Genentech/Roche: Consultancy, Research Funding; ATB Therapeutics: Consultancy; Foresight Diagnostics: Consultancy; Kite - a Gilead company: Research Funding; Adaptive Biotechnologies: Research Funding; IGM: Research Funding; AstraZeneca: Consultancy, Research Funding; MSD: Consultancy, Research Funding; Tessa Therapeutics: Consultancy; Regeneron: Consultancy; Xencor: Consultancy; Affimed Therapeutics: Research Funding. Casulo: Genentech: Consultancy, Research Funding; GenMab: Research Funding; Gilead Sciences: Research Funding; SecuraBio: Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Verastem: Research Funding; Abbvie: Consultancy; Follicular Lymphoma Foundation: Other: Leadership role; Lymphoma Research Foundation: Other: Leadership Role.
On Demand program will be available here January 8, 2024.
This 90-minute symposium will feature 3 experts in treating HL and is designed to highlight recent clinical trial data in cHL, real-world outcomes, and provide patient case examples on how to translate these data into clinical practice. Panel discussion and audience polling questions will be interwoven throughout the program to enhance dialogue.
See more of: Friday Satellite Symposia